Published in Neurobiol Dis on January 22, 2010
Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation. J Neural Transm (Vienna) (2011) 1.12
Potential mechanisms underlying anxiety and depression in Parkinson's disease: consequences of l-DOPA treatment. Neurosci Biobehav Rev (2010) 0.96
Noradrenaline and Parkinson's disease. Front Syst Neurosci (2011) 0.94
Presynaptic control of serotonin on striatal dopamine function. Psychopharmacology (Berl) (2010) 0.93
Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications. Front Neurol (2014) 0.92
L-DOPA-induced dysregulation of extrastriatal dopamine and serotonin and affective symptoms in a bilateral rat model of Parkinson's disease. Neuroscience (2012) 0.88
Use of [18F]FDOPA-PET for in vivo evaluation of dopaminergic dysfunction in unilaterally 6-OHDA-lesioned rats. EJNMMI Res (2011) 0.86
Dopamine release from serotonergic nerve fibers is reduced in L-DOPA-induced dyskinesia. J Neurochem (2011) 0.86
Serotonin transporter inhibition attenuates l-DOPA-induced dyskinesia without compromising l-DOPA efficacy in hemi-parkinsonian rats. Eur J Neurosci (2012) 0.86
L-dopa-induced dopamine synthesis and oxidative stress in serotonergic cells. Neuropharmacology (2012) 0.84
Role of the primary motor cortex in L-Dopa-induced dyskinesia and its modulation by 5-HT1A receptor stimulation. Neuropharmacology (2011) 0.84
Depression of Serotonin Synaptic Transmission by the Dopamine Precursor L-DOPA. Cell Rep (2015) 0.84
Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson's disease. Front Neural Circuits (2014) 0.84
Effects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemi-parkinsonian rats. Neuropharmacology (2013) 0.82
Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia. Parkinsons Dis (2011) 0.82
Catecholamine/Serotonin interactions: systems thinking for brain function and disease. Adv Pharmacol (2013) 0.82
Behavioral and neurochemical effects of chronic L-DOPA treatment on nonmotor sequelae in the hemiparkinsonian rat. Behav Pharmacol (2010) 0.82
The acute and long-term L-DOPA effects are independent from changes in the activity of dorsal raphe serotonergic neurons in 6-OHDA lesioned rats. Br J Pharmacol (2016) 0.81
In vivo catecholaminergic metabolism in the medial prefrontal cortex of ENU2 mice: an investigation of the cortical dopamine deficit in phenylketonuria. J Inherit Metab Dis (2012) 0.81
Dopamine transporter loss in 6-OHDA Parkinson's model is unmet by parallel reduction in dopamine uptake. PLoS One (2012) 0.80
L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum. Sci Rep (2014) 0.80
Functional correlates of exaggerated oscillatory activity in basal ganglia output in hemiparkinsonian rats. Exp Neurol (2014) 0.80
Increased L-DOPA-derived dopamine following selective MAO-A or -B inhibition in rat striatum depleted of dopaminergic and serotonergic innervation. Br J Pharmacol (2013) 0.80
Multisite intracerebral microdialysis to study the mechanism of L-DOPA induced dopamine and serotonin release in the parkinsonian brain. ACS Chem Neurosci (2013) 0.80
Chronic L-dopa decreases serotonin neurons in a subregion of the dorsal raphe nucleus. J Pharmacol Exp Ther (2014) 0.80
Presynaptic effects of levodopa and their possible role in dyskinesia. Mov Disord (2014) 0.80
Serotonin System Implication in l-DOPA-Induced Dyskinesia: From Animal Models to Clinical Investigations. Front Neurol (2014) 0.79
Relationship between L-DOPA-induced reduction in motor and exploratory activity and degree of DAT binding in the rat. Front Behav Neurosci (2014) 0.79
Tryptophan hydroxylase 2 aggregates through disulfide cross-linking upon oxidation: possible link to serotonin deficits and non-motor symptoms in Parkinson's disease. J Neurochem (2010) 0.78
Deuterium-substituted L-DOPA displays increased behavioral potency and dopamine output in an animal model of Parkinson's disease: comparison with the effects produced by L-DOPA and an MAO-B inhibitor. J Neural Transm (Vienna) (2014) 0.77
Differential dopamine receptor occupancy underlies L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. PLoS One (2014) 0.77
Behavioral impairments and serotonin reductions in rats after chronic L-dopa. Psychopharmacology (Berl) (2015) 0.76
Relationship Between L-DOPA-Induced Reduction in Motor and Exploratory Activity and Striatal Dopamine D2 Receptor Binding in the Rat. Front Behav Neurosci (2016) 0.75
The enhanced oral response to the 5-HT2 agonist Ro 60-0175 in parkinsonian rats involves the entopeduncular nucleus: electrophysiological correlates. Exp Brain Res (2013) 0.75
Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases. Front Neurosci (2016) 0.75
Impairment of Serotonergic Transmission by the Antiparkinsonian Drug L-DOPA: Mechanisms and Clinical Implications. Front Cell Neurosci (2017) 0.75
Ets ternary complex transcription factors. Gene (2004) 2.99
Charité total disc replacement--clinical and radiographical results after an average follow-up of 17 years. Eur Spine J (2005) 2.75
Subthalamic high frequency stimulation resets subthalamic firing and reduces abnormal oscillations. Brain (2005) 2.19
Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive-compulsive disorder and major depression. Case report. J Neurosurg (2004) 2.09
The effects of coffee and napping on nighttime highway driving: a randomized trial. Ann Intern Med (2006) 2.04
Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function. Nat Med (2003) 1.73
Sleep disorders in Parkinson's disease: the contribution of the MPTP non-human primate model. Exp Neurol (2009) 1.70
Lack of agreement between direct magnetic resonance imaging and statistical determination of a subthalamic target: the role of electrophysiological guidance. J Neurosurg (2002) 1.68
Fatigue, sleep restriction and driving performance. Accid Anal Prev (2005) 1.60
High-frequency stimulation in Parkinson's disease: more or less? Trends Neurosci (2005) 1.59
Neuronal correlates of obsessions in the caudate nucleus. Biol Psychiatry (2007) 1.58
Meta-analysis of brain volume changes in obsessive-compulsive disorder. Biol Psychiatry (2008) 1.55
Continuous positive airway pressure for sleep-related breathing disorders in multiple system atrophy: long-term acceptance. Sleep Med (2005) 1.50
Validation of Horne and Ostberg morningness-eveningness questionnaire in a middle-aged population of French workers. J Biol Rhythms (2004) 1.47
Deep brain stimulation for Parkinson's disease: potential risk of tissue damage associated with external stimulation. Ann Neurol (2004) 1.42
Pathophysiology of obsessive-compulsive disorder: a necessary link between phenomenology, neuropsychology, imagery and physiology. Prog Neurobiol (2004) 1.40
Latest view on the mechanism of action of deep brain stimulation. Mov Disord (2008) 1.39
Provocation of obsessive-compulsive symptoms: a quantitative voxel-based meta-analysis of functional neuroimaging studies. J Psychiatry Neurosci (2008) 1.39
Sleep disorders and accidental risk in a large group of regular registered highway drivers. Sleep Med (2010) 1.31
Dual effect of high-frequency stimulation on subthalamic neuron activity. J Neurosci (2003) 1.30
Effects of sleep deprivation on Color-Word, Emotional, and Specific Stroop interference and on self-reported anxiety. Brain Cogn (2005) 1.30
Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease. Eur J Neurosci (2004) 1.30
The circadian and homeostatic modulation of sleep pressure during wakefulness differs between morning and evening chronotypes. J Sleep Res (2003) 1.29
Late emergence of synchronized oscillatory activity in the pallidum during progressive Parkinsonism. Eur J Neurosci (2007) 1.27
Shaping of motor responses by incentive values through the basal ganglia. J Neurosci (2007) 1.24
From single extracellular unit recording in experimental and human Parkinsonism to the development of a functional concept of the role played by the basal ganglia in motor control. Prog Neurobiol (2002) 1.17
Age, performance and sleep deprivation. J Sleep Res (2004) 1.17
5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum. Neuropsychopharmacology (2002) 1.17
Dynamic changes in the cortex-basal ganglia network after dopamine depletion in the rat. J Neurophysiol (2008) 1.15
Fatigue, sleepiness, and performance in simulated versus real driving conditions. Sleep (2005) 1.14
Gray matter alterations in obsessive-compulsive disorder: an anatomic likelihood estimation meta-analysis. Neuropsychopharmacology (2009) 1.12
Light-cone-like spreading of correlations in a quantum many-body system. Nature (2012) 1.09
D5 (not D1) dopamine receptors potentiate burst-firing in neurons of the subthalamic nucleus by modulating an L-type calcium conductance. J Neurosci (2003) 1.06
Observation of spatially ordered structures in a two-dimensional Rydberg gas. Nature (2012) 1.05
The 'Higgs' amplitude mode at the two-dimensional superfluid/Mott insulator transition. Nature (2012) 1.05
Dynamic stabilization adjacent to single-level fusion: part II. No clinical benefit for asymptomatic, initially degenerated adjacent segments after 6 years follow-up. Eur Spine J (2010) 1.04
Dynamic stabilization adjacent to single-level fusion: part I. Biomechanical effects on lumbar spinal motion. Eur Spine J (2010) 1.03
Chronic L-DOPA therapy alters central serotonergic function and L-DOPA-induced dopamine release in a region-dependent manner in a rat model of Parkinson's disease. Neurobiol Dis (2010) 1.02
Aging and nocturnal driving: better with coffee or a nap? A randomized study. Sleep (2007) 1.00
In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum. Neuropsychopharmacology (2004) 0.99
Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine. Neurobiol Dis (2006) 0.99
Impact of high-frequency stimulation parameters on the pattern of discharge of subthalamic neurons. J Neurophysiol (2005) 0.99
Fatigue, sleep restriction, and performance in automobile drivers: a controlled study in a natural environment. Sleep (2003) 0.99
Acute versus chronic partial sleep deprivation in middle-aged people: differential effect on performance and sleepiness. Sleep (2012) 0.98
The ternary complex factor Net regulates cell migration through inhibition of PAI-1 expression. Mol Cell Biol (2005) 0.98
Deep brain stimulation for OCD and major depression. Am J Psychiatry (2005) 0.98
Microscopic observation of magnon bound states and their dynamics. Nature (2013) 0.96
Allogenic versus autologous cancellous bone in lumbar segmental spondylodesis: a randomized prospective study. Eur Spine J (2009) 0.95
Stand-alone anterior versus anteroposterior lumbar interbody single-level fusion after a mean follow-up of 41 months. J Spinal Disord Tech (2012) 0.95
Sleepiness, near-misses and driving accidents among a representative population of French drivers. J Sleep Res (2010) 0.95
Maintenance of wakefulness test as a predictor of driving performance in patients with untreated obstructive sleep apnea. Sleep (2007) 0.95
High-frequency stimulation of the subthalamic nucleus and L-3,4-dihydroxyphenylalanine inhibit in vivo serotonin release in the prefrontal cortex and hippocampus in a rat model of Parkinson's disease. J Neurosci (2010) 0.94
A nationwide survey of excessive daytime sleepiness in Parkinson's disease in France. Mov Disord (2007) 0.94
Sharp and sleepy: evidence for dissociation between sleep pressure and nocturnal performance. J Sleep Res (2008) 0.94
Presynaptic control of serotonin on striatal dopamine function. Psychopharmacology (Berl) (2010) 0.93
Updated overview of the putative role of the serotoninergic system in obsessive-compulsive disorder. Neuropsychiatr Dis Treat (2005) 0.93
Maintenance of Wakefulness Test, obstructive sleep apnea syndrome, and driving risk. Ann Neurol (2008) 0.93
Sleep duration and caffeine consumption in a French middle-aged working population. Sleep Med (2005) 0.92
Extended driving impairs nocturnal driving performances. PLoS One (2008) 0.91
Anatomical alterations and symptom-related functional activity in obsessive-compulsive disorder are correlated in the lateral orbitofrontal cortex. Biol Psychiatry (2009) 0.91
Distinct striatal targets in treating obsessive-compulsive disorder and major depression. J Neurosurg (2009) 0.91
Noradrenergic modulation of subthalamic nucleus activity: behavioral and electrophysiological evidence in intact and 6-hydroxydopamine-lesioned rats. J Neurosci (2007) 0.90
Primate models of dystonia. Prog Neurobiol (2008) 0.90
Temporal and spatial alterations in GPi neuronal encoding might contribute to slow down movement in Parkinsonian monkeys. Eur J Neurosci (2006) 0.90
Altered pallido-pallidal synaptic transmission leads to aberrant firing of globus pallidus neurons in a rat model of Parkinson's disease. J Physiol (2012) 0.90
Evolution of the dynamic properties of the cortex-basal ganglia network after dopaminergic depletion in rats. Neurobiol Dis (2012) 0.89
Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease. Eur J Pharmacol (2003) 0.89
Synchronous high-voltage spindles in the cortex-basal ganglia network of awake and unrestrained rats. Eur J Neurosci (2007) 0.89
The Subthalamic Nucleus becomes a Generator of Bursts in the Dopamine-Depleted State. Its High Frequency Stimulation Dramatically Weakens Transmission to the Globus Pallidus. Front Syst Neurosci (2011) 0.88
[Inhibition and working memory: effect of acute sleep deprivation on a random letter generation task]. Can J Exp Psychol (2003) 0.86
Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum. Eur J Neurosci (2003) 0.86
Classical bifurcation at the transition from Rabi to Josephson dynamics. Phys Rev Lett (2010) 0.85
The tumor suppressor p53 inhibits Net, an effector of Ras/extracellular signal-regulated kinase signaling. Mol Cell Biol (2004) 0.85
Intrastriatal administration of sigma ligands inhibits basal dopamine release in vivo. Neuropharmacology (2003) 0.85
Disruption of the proprioceptive mapping in the medial wall of parkinsonian monkeys. Ann Neurol (2002) 0.84
Auditory temporal processing in Parkinson's disease. Neuropsychologia (2008) 0.84
Dopamine transporter knock-out mice are hypersensitive to 3-nitropropionic acid-induced striatal damage. Eur J Neurosci (2002) 0.83
Brain-derived neurotrophic factor and the plasticity of the mesolimbic dopamine pathway. Int Rev Neurobiol (2004) 0.83
Contribution of serotonergic transmission to the motor and cognitive effects of high-frequency stimulation of the subthalamic nucleus or levodopa in Parkinson's disease. Mol Neurobiol (2012) 0.83
Nocturnal sustained attention during sleep deprivation can be predicted by specific periods of subjective daytime alertness in normal young humans. J Sleep Res (2006) 0.82
Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia. Parkinsons Dis (2011) 0.82
Catecholamine/Serotonin interactions: systems thinking for brain function and disease. Adv Pharmacol (2013) 0.82
Pattern of levodopa-induced striatal changes is different in normal and MPTP-lesioned mice. J Neurochem (2003) 0.82
Noradrenergic terminals regulate L-DOPA-derived dopamine extracellular levels in a region-dependent manner in Parkinsonian rats. CNS Neurosci Ther (2014) 0.81
High-frequency stimulation of both zona incerta and subthalamic nucleus induces a similar normalization of basal ganglia metabolic activity in experimental parkinsonism. FASEB J (2004) 0.81
Role(s) of the 5-HT2C receptor in the development of maximal dentate activation in the hippocampus of anesthetized rats. CNS Neurosci Ther (2014) 0.80
Periosteal cells compared with autologous cancellous bone in lumbar segmental fusion. J Neurosurg Spine (2008) 0.80
Central serotonin4 receptors selectively regulate the impulse-dependent exocytosis of dopamine in the rat striatum: in vivo studies with morphine, amphetamine and cocaine. Neuropharmacology (2002) 0.80
L-DOPA and serotonergic neurons: functional implication and therapeutic perspectives in Parkinson's disease. Cent Nerv Syst Agents Med Chem (2011) 0.80
[Deep brain stimulation of the ventral striatum in the treatment of obsessive-compulsive disorder and major depression]. Med Sci (Paris) (2005) 0.80
Genes regulated in MPTP-treated macaques and human Parkinson's disease suggest a common signature in prefrontal cortex. Neurobiol Dis (2010) 0.80
Which radiographic parameters are linked to failure of a dynamic spinal implant? Clin Orthop Relat Res (2012) 0.79
Insomniac complaints interfere with quality of life but not with absenteeism: respective role of depressive and organic comorbidity. Sleep Med (2006) 0.79